I see you are playing the "no cash" card. According to the most recent 10-Q, IPIX has $5.6M cash on hand and $16M left in Aspire. They expect to spend $14M in the next 12 months, so they need about $8.4M from Aspire. They also have $42.8M in shelf registration.
Can you provide some #s to back up your statment of "a deepening financial hole"?
(1)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links